By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Investment house William Blair on Monday initiated coverage of Pacific Biosciences and Complete Genomics.

Analyst Amanda Murphy gave PacBio a "Market Perform" rating and an "Aggressive Growth" profile, and in a research note, said that the Menlo Park, Calif.-based firm is "on track to be the first company to successfully commercialize third-generation sequencing technology."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.

The New York Times editorial board weighs in on scientific research misconduct.

The European Commission says it won't take funds from the European Research Council's budget for its new European Fund for Strategic Investment.

The case of the 'devious defecator' examines the protections of the Genetic Information Nondiscrimination Act.